Intrinsic Value of S&P & Nasdaq Contact Us

Anixa Biosciences, Inc. ANIX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
57/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.83
+102.4%

Stock Statistics — ANIX

Anixa Biosciences, Inc. (ANIX) has a market capitalization of $96.56M and trades at $2.88. The 52-week range is 2.33-5.46.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -8.5, Earnings Per Share (EPS) of $-0.34.

The stock has a beta of 0.58, operates in the Healthcare sector.

Trading Data
Current Price$2.88
52-Week Range2.33-5.46
Volume111.1K
Avg Volume (30D)139.05K
Market Cap$96.56M
Beta (1Y)0.58
Company
IPO Date1983-10-07
Employees5
CEOAmit Kumar
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS03528H1095
CUSIP03528H109
Income (Latest Year)
Gross Profit$-36K
EBITDA$-11.7M
Operating Income$-11.7M
Net Income$-10.93M
EPS$-0.34
EPS Diluted$-0.34
Shares Outstanding$32.45M
Balance Sheet (Latest Year)
Total Assets$16.08M
Current Assets$15.89M
Cash & ST Investments$15.17M
Total Liabilities$2.13M
Total Debt$204K
Net Debt$-1.04M
Total Equity$13.95M
Debt / Equity0.01
Valuation Ratios
P/E Ratio-8.5
P/B Ratio6.92
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message